Search Results

You are looking at 1 - 10 of 12 items for :

  • "postmenopause" x
Clear All
Restricted access

Julia C. Orri, Elizabeth M. Hughes, Deepa G. Mistry and Antone Scala

. VO 2 max correlated negatively with α1 at rest ( r  = −.34, p  < .05; N  = 36) and positively with α1/α2 during exercise ( r  = .39, p  < .05; N  = 36). Discussion The major findings of this study were as follows: (a) maximal exercise in postmenopause reduced the time domain and nonlinear HRV

Restricted access

Darryn S. Willoughby, Kaitlan N. Beretich, Marcus Chen and LesLee K. Funderburk

point, the participants self-identified on a previously established reproductive age screening form whether they were PERI-M or POST-M ( Harlow et al., 2012 ). The women rated themselves in one of three stages: reproductive, perimenopause, or postmenopause. Those who rated themselves in the reproductive

Restricted access

Susan Sullivan Glenney, Derrick Paul Brockemer, Andy C. Ng, Michael A. Smolewski, Vladimir M. Smolgovskiy and Adam S. Lepley

statins OR copd OR hiv OR “nerve repair” OR #6: “Cardiac Surgery” OR cancer OR neoplasm OR neoplasms OR “drug effects” OR pharmacolog OR pharmacology OR pharmacological OR pharmaceutic OR pharmaceutic OR pharmaceutical OR “drug therapy” OR “multiple sclerosis” OR postmenopause OR postmenopausal OR post-menopause

Restricted access

Megan S. Farris, Kerry S. Courneya, Rachel O’Reilly and Christine M. Friedenreich

.1136/bmjopen-2012-001044 22798253 10.1136/bmjopen-2012-001044 10. Conroy MB , Simkin-Silverman LR , Pettee KK , Hess R , Kuller LH , Kriska AM . Lapses and psychosocial factors related to physical activity in early postmenopause . Med Sci Sports Exerc . 2007 ; 39 ( 10 ): 1858 – 1866

Restricted access

Panagiota Klentrou, Kirina Angrish, Nafisa Awadia, Nigel Kurgan, Rozalia Kouvelioti and Bareket Falk

). The authors attributed these findings to the increase in estrogen concentration following the onset of puberty, which reduces sclerostin levels until postmenopause. Indeed, previous studies have found sclerostin associated with low estrogen levels in postmenopausal women, who have higher sclerostin

Restricted access

Catrine Tudor-Locke, John M. Schuna Jr, Damon L. Swift, Amber T. Dragg, Allison B. Davis, Corby K. Martin, William D. Johnson and Timothy S. Church

% of the adult population meets commonly recommended amounts (ie, 30 min/d) of objectively monitored MVPA, with the lowest prevalence observed in women aged 50 years and older, 6 an age range also associated with postmenopause-related increases in the prevalence of hypertension. Furthermore, the Dose

Restricted access

Rochelle R. Costa, Adriana C.K. Buttelli, Leandro Coconcelli, Laura F. Pereira, Alexandra F. Vieira, Alex de O. Fagundes, Juliano B. Farinha, Thais Reichert, Ricardo Stein and Luiz F.M. Kruel

, reduced estrogen levels linked with the postmenopause phase may favor the diagnosis of different lipoprotein disorders. These metabolic alterations can be deleterious to the arterial endothelial layer, inducing the atherosclerotic process and increasing the risk of cardiovascular events, such as

Restricted access

Maja Zamoscinska, Irene R. Faber and Dirk Büsch

.0 at hip and/or spine). Exclusion criteria: (1) after lower limb joint surgery or injury, (2) recent fracture (within the last 12 mo) or localized back pain, (3) less than 5 y postmenopause, (4) malignancy, (5) uncontrolled cardiovascular disease, (6) cognitive impairment, (7) recent X-ray or radiation

Restricted access

Alexei Wong and Arturo Figueroa

significant changes in body weight, BMI, lean mass and BF% after LIRET or control. Table 1 Subjects Characteristics Before and After 12 Weeks of LIRET or Control Control LIRET Variable Before After Before After Age (years) 55 ± 1 – 54 ± 1 – Postmenopause (years) 4 ± 1 – 4 ± 1 – Height (m) 1.63 ± 0.02 – 1

Restricted access

Ian M. Greenlund, Piersan E. Suriano, Steven J. Elmer, Jason R. Carter and John J. Durocher

should be minimized by the similar distribution of women in each phase/status (ie, early follicular, mid-luteal, perimenopause, and postmenopause). Distributions were 37%, 26%, 5%, and 26% in seated participants, and 24%, 24%, 5%, and 38%, respectively in standing participants. About 5% chose not to